Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic

  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

GT Biopharma Inc (NQ: GTBP )

2.450 -0.160 (-6.13%)
Streaming Delayed Price Updated: 10:59 AM EDT, May 27, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 29,231
Open 2.510
Bid (Size) 2.460 (1)
Ask (Size) 2.500 (3)
Prev. Close 2.610
Today's Range 2.380 - 2.620
52wk Range 1.510 - 19.73
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
81 Biggest Movers From Yesterday
Gainers Eos Energy Enterprises, Inc. (NASDAQ: EOSE) shares gained 41.8% to settle at $1.90 on Tuesday. Eos Energy Enterprises recently reported worse-than-expected Q1 EPS and sales results. 
Via Benzinga
GT Biopharma: Q1 Earnings Insights
GT Biopharma (NASDAQ:GTBP) reported its Q1 earnings results on Monday, May 16, 2022 at 08:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga

Performance

YTD
-23.20%
-23.20%
1 Month
+21.89%
+21.89%
3 Month
-22.47%
-22.47%
6 Month
-44.70%
-44.70%
1 Year
-84.71%
-84.71%

More News

Read More
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
Via Benzinga
Exposures Product Safety
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Mid-Afternoon Market Update: eHealth Drops Following Q3 Results; Autolus Therapeutics Shares Gain
Via Benzinga
Topics Stocks
Exposures US Equities
Stocks Hitting New 52-Week Lows Today
Via Benzinga
Mid-Day Market Update: Trade Desk Jumps After Upbeat Results; GT Biopharma Shares Slide
Via Benzinga
Topics Stocks
Exposures US Equities
38 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
64 Biggest Movers From Yesterday
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Mid-Morning Market Update: Markets Rise; Coty Posts Upbeat Earnings
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
38 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
60 Biggest Movers From Yesterday
Via Benzinga
Earnings Scheduled For August 13, 2021
Via Benzinga
60 Biggest Movers From Yesterday
Via Benzinga
The Daily Biotech Pulse: Merck Completes Organon Spin-Off, Auris Repositions As RNA Therapeutic Company With Trasir Purchase, Replimune's Readout
Via Benzinga
The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO
Via Benzinga
Exposures Product Safety
61 Biggest Movers From Yesterday
Via Benzinga
63 Biggest Movers From Friday
Via Benzinga
Exposures Product Safety
The Daily Biotech Pulse: AstraZeneca, Biogen Face Clinical Trial Disappointments, Novavax Studies Coronavirus-Flu Combo Vaccine, Decision Day For Takeda
Via Benzinga
55 Biggest Movers From Yesterday
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.